Skip to main content
Top
Published in:

03-01-2024 | Colorectal Cancer | Original Paper

Evaluation of the effectiveness of colorectal cancer screening intervention

Authors: Guven Turan, Merve Turan, Hatice Ikiisik, Mahmut Emre Yildirim, Mustafa Cakir, Isil Maral

Published in: Cancer Causes & Control | Issue 5/2024

Login to get access

Abstract

Purpose

The effectiveness of the Colorectal Cancer (CRC) screening program is assessed based on the reduction in CRC mortality and incidence rates over time. To accurately estimate the long-term impact, it is advisable to monitor additional indicators such as age and stage-specific incidence rates. Our objective is to evaluate the effectiveness of the National CRC Screening Program in Turkey and analyze its influence on disease stage at diagnosis and survival rates.

Methods

The National CRC Screening Program was considered an intervention and the distribution of local, regional, and distant diseases, and survival estimates were assessed before and after the intervention to evaluate the effectiveness of the intervention.

Results

518 patients were included in the study. At the time of diagnosis, localized, regional, and distant disease in pre-intervention were 31.3%, 42.9%, 25.8%, while post-intervention were 42.8%, 33.3%, 23.9%, respectively (p = 0.020). The relative effectiveness of the intervention in males, females, and 50–70 ages were calculated as 1.2[95% CI 0.95–1.73], 1.5[95% CI 1.04–2.18], and 1.6[95% CI 1.21–2.28] in localized disease, 0.8[95% CI 0.67–1.18], 0.6[95% CI 0.43–0.90], and 0.6[95% CI 0.46–0.81] in regional diseases, 0.8[95% CI 0.57–1.20], 1.1[95% CI 0.66–1.84], and 1.0[95% CI 0.70–1.57] in distant disease, respectively.

Conclusion

A noticeable shift in the disease stage at the time of diagnosis was observed; however, this shift varied among gender and age groups. To effectively evaluate the impact of a cancer screening program on reducing the incidence and mortality rates of the disease, it is essential to monitor and analyze these indicators alongside 5–10-year survival estimates and stage changes at the time of diagnosis.
Literature
4.
go back to reference Øines M, Helsingen LM, Bretthauer M, Emilsson L (2017) Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol 31(4):419–424CrossRefPubMed Øines M, Helsingen LM, Bretthauer M, Emilsson L (2017) Epidemiology and risk factors of colorectal polyps. Best Pract Res Clin Gastroenterol 31(4):419–424CrossRefPubMed
13.
go back to reference Guimarães DP, Mantuan LA, de Oliveira MA, Junior RL, Costa AMD, Rossi S, Fava G, Taveira LN, Giardina KM, Talarico T, Costa M, Scapulatempo-Neto C, Matsushita MM, Véo CA, Fregnani JHT, Reis RM, Hawk ET, Mauad EC (2021) The performance of colorectal cancer screening in Brazil: The first two years of the implementation program in Barretos Cancer Hospital. Cancer Prev Res (Phila) 14(2):241–252. https://doi.org/10.1158/1940-6207.CAPR-20-017)CrossRefPubMed Guimarães DP, Mantuan LA, de Oliveira MA, Junior RL, Costa AMD, Rossi S, Fava G, Taveira LN, Giardina KM, Talarico T, Costa M, Scapulatempo-Neto C, Matsushita MM, Véo CA, Fregnani JHT, Reis RM, Hawk ET, Mauad EC (2021) The performance of colorectal cancer screening in Brazil: The first two years of the implementation program in Barretos Cancer Hospital. Cancer Prev Res (Phila) 14(2):241–252. https://​doi.​org/​10.​1158/​1940-6207.​CAPR-20-017)CrossRefPubMed
15.
go back to reference Özdemir R, Turkmen Çevik F, Kes D, Karacali M, Özguner S (2020) Level and factors associated with participation in population-based cancer screening in Safranbolu District of Karabuk, Turkey. Iran J Public Health 49(4):663–672PubMedPubMedCentral Özdemir R, Turkmen Çevik F, Kes D, Karacali M, Özguner S (2020) Level and factors associated with participation in population-based cancer screening in Safranbolu District of Karabuk, Turkey. Iran J Public Health 49(4):663–672PubMedPubMedCentral
17.
go back to reference Bakar C, Oymak S, Maral I (2017) Turkey’s epidemiological and demographic transitions: 1931–2013. Balkan Med J 34(4):323–334PubMedPubMedCentral Bakar C, Oymak S, Maral I (2017) Turkey’s epidemiological and demographic transitions: 1931–2013. Balkan Med J 34(4):323–334PubMedPubMedCentral
19.
21.
go back to reference Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V (2016) Colorectal Cancer Screening Programme in Spain: results of key performance indicators after five rounds (2000–2012). Sci Rep 20(6):19532. https://doi.org/10.1038/srep19532CrossRef Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V (2016) Colorectal Cancer Screening Programme in Spain: results of key performance indicators after five rounds (2000–2012). Sci Rep 20(6):19532. https://​doi.​org/​10.​1038/​srep19532CrossRef
22.
go back to reference von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 40(3):712–718. https://doi.org/10.1093/ije/dyr008CrossRef von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S, Smith S, Halloran S, Wardle J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 40(3):712–718. https://​doi.​org/​10.​1093/​ije/​dyr008CrossRef
24.
go back to reference Senore C, Basu P, Anttila A, Ponti A, Tomatis M, Vale DB, Ronco G, Soerjomataram I, Primic-Žakelj M, Riggi E, Dillner J, Elfström MK, Lönnberg S, Sankaranarayanan R, Segnan N (2019) Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut 68(7):1232–1244. https://doi.org/10.1136/gutjnl-2018-317293CrossRefPubMed Senore C, Basu P, Anttila A, Ponti A, Tomatis M, Vale DB, Ronco G, Soerjomataram I, Primic-Žakelj M, Riggi E, Dillner J, Elfström MK, Lönnberg S, Sankaranarayanan R, Segnan N (2019) Performance of colorectal cancer screening in the European Union Member States: data from the second European screening report. Gut 68(7):1232–1244. https://​doi.​org/​10.​1136/​gutjnl-2018-317293CrossRefPubMed
Metadata
Title
Evaluation of the effectiveness of colorectal cancer screening intervention
Authors
Guven Turan
Merve Turan
Hatice Ikiisik
Mahmut Emre Yildirim
Mustafa Cakir
Isil Maral
Publication date
03-01-2024
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 5/2024
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01839-z

ASH 2024 Annual Meeting Coverage

inMIND supports tafasitamab addition in follicular lymphoma

Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.

Featuring the official presentation video

Read more
SPONSORED

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by:
  • Novartis Pharma AG
Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Watch now